Pharma & Biotech

Facing the impending loss of patent protection for its blockbuster drug Stelara in 2025, Johnson & Johnson has been under...

As Sangamo Therapeutics advances its gene therapy candidate for Fabry disease, investor focus is split between imminent regulatory milestones and...

Bayer, the German pharmaceutical and life sciences giant headquartered in Leverkusen, is currently steering through a period of significant international...

Tilray Brands unveiled a trio of strategic announcements this week, spanning pharmaceutical distribution, beverage launches, and international acquisitions. Despite these...

Anixa Biosciences is intensifying its strategic focus on a pair of clinical-stage oncology assets. In a recent update, the company’s...

Despite facing notable share price pressure since the start of the year, Danaher's management is projecting confidence through a significant...

Legend Biotech Corp has reached a pivotal financial turning point. The company's cell therapy, CARVYKTI, became profitable in the last...

Talphera has achieved a significant enrollment milestone for its lead investigational drug, Niyad. The company announced that patient recruitment for...

The German pharmaceutical packaging specialist Gerresheimer finds itself in a severe predicament, facing a perfect storm of delayed financial reporting,...

The architects of Germany's celebrated vaccine breakthrough are stepping back from day-to-day leadership. BioNTech SE's co-founders, Uğur Şahin and Özlem...